| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.08B | 12.29B | 10.68B | 11.25B | 9.82B | 9.01B |
| Gross Profit | 3.32B | 3.27B | 2.50B | 2.33B | 2.14B | 2.08B |
| EBITDA | 2.37B | 2.39B | 1.70B | 1.63B | 1.47B | 1.49B |
| Net Income | 1.59B | 1.58B | 1.09B | 1.09B | 967.39M | 982.27M |
Balance Sheet | ||||||
| Total Assets | 10.73B | 11.38B | 9.12B | 8.02B | 7.05B | 7.01B |
| Cash, Cash Equivalents and Short-Term Investments | 5.02B | 4.12B | 2.40B | 2.28B | 2.98B | 1.71B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 300.00M |
| Total Liabilities | 2.65B | 3.16B | 2.13B | 1.80B | 1.61B | 2.23B |
| Stockholders Equity | 8.07B | 8.22B | 6.99B | 6.22B | 5.44B | 4.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.12B | 402.51M | -271.24M | 1.88B | -28.72M |
| Operating Cash Flow | 0.00 | 2.14B | 510.81M | -222.20M | 1.90B | 23.69M |
| Investing Cash Flow | 0.00 | -78.29M | -43.94M | -154.21M | -41.94M | -64.45M |
| Financing Cash Flow | 0.00 | -348.44M | -348.02M | -317.36M | -595.55M | 125.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥14.14B | 9.52 | ― | 3.91% | 12.31% | 1.81% | |
77 Outperform | ¥14.01B | 11.13 | ― | 3.97% | 5.33% | -27.53% | |
71 Outperform | ¥12.43B | 12.02 | ― | 4.39% | 2.65% | 45.12% | |
70 Outperform | ¥14.78B | 11.04 | ― | 2.65% | 28.80% | 5.92% | |
64 Neutral | ¥11.36B | 4.48 | ― | 2.33% | 7.66% | 562.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥10.45B | 22.00 | ― | 2.74% | 4.36% | 17.63% |